Zevra Therapeutics (ZVRA) Asset Utilization Ratio (2019 - 2026)
Zevra Therapeutics' Asset Utilization Ratio was 0.48 in Q3 2026, up 49.6% from 0.32 a year earlier and up 2.4% from the prior quarter.
Powered by 
Analysis
Zevra Therapeutics (ZVRA) Asset Utilization Ratio (2019 - 2026) Analysis & Trends
For FY2025, Asset Utilization Ratio at Zevra Therapeutics came in at 0.46, up 241.5% from FY2024.
- In earlier years, Asset Utilization Ratio was 0.13 in FY2024 (-29.4%), 0.19 in FY2023 (+133.3%), 0.08 in FY2022 (-79.4%) and 0.40 in FY2021 (-67.5%).
- The Q3 2026 figure marks the highest quarterly Asset Utilization Ratio since Q4 2020.
- Compared with a year earlier, Asset Utilization Ratio has increased for seven straight quarters, with growth averaging 76.0% over the last eight quarters.
- The best year-over-year quarter for Asset Utilization Ratio over five years was Q4 2025 (growth of 201.0%); the worst was Q4 2021 (a decline of 82.1%).
- Per Business Quant data, ZVRA's Asset Utilization Ratio in the three quarters before Q3 2026 was 0.47 (Q2 2026), 0.43 (Q1 2026) and 0.38 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 0.60 |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 0.50 |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 0.47 |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 0.51 |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 0.50 |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 0.41 |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 0.62 |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 0.31 |
| 10 | Zevra Therapeutics | 708.52 Mn | -100.24 Mn | 36.01 Mn | 0.48 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 0.48 |
| Jun 30, 2026 | 0.47 |
| Mar 31, 2026 | 0.43 |
| Dec 31, 2025 | 0.38 |
| Sep 30, 2025 | 0.32 |
| Jun 30, 2025 | 0.29 |
| Mar 31, 2025 | 0.23 |
| Dec 31, 2024 | 0.13 |
| Sep 30, 2024 | 0.15 |
| Jun 30, 2024 | 0.16 |
| Mar 31, 2024 | 0.17 |
| Dec 31, 2023 | 0.18 |
| Sep 30, 2023 | 0.14 |
| Jun 30, 2023 | 0.16 |
| Mar 31, 2023 | 0.08 |
| Dec 31, 2022 | 0.09 |
| Sep 30, 2022 | 0.09 |
| Jun 30, 2022 | 0.08 |
| Mar 31, 2022 | 0.16 |
| Dec 31, 2021 | 0.21 |
API Access
Zevra Therapeutics Asset Utilization Ratio API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ZVRA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "asset-utilization-ratio", "ticker": "ZVRA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=asset-utilization-ratio&ticker=ZVRA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();